CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 4 Shares withheld for taxes President & CEO gave up 10,086 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 40,000 shares (grant or award)
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
Page 23 of 33 · 652 filings